Evidence map›Paper›PMID 28698334›Full record

Trial reportBMJ open2017

A randomised controlled trial to evaluate the impact of sexual health clinic based automated text message reminders on testing of HIV and other sexually transmitted infections in men who have sex with men in China: protocol for the T2T Study.

Huachun Zou, Xiaojun Meng, Andrew Grulich, Shujie Huang, Tianjian Jia, Xuan Zhang, Zhenzhou Luo, Yi Ding, Ligang Yang, Jinmei Huang and 3 more

Erratum issuedAbstract readRandomized Controlled Trial
PubMed Full text at PMC Publisher
In one paragraph

Trial report in BMJ open, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

  • Erratum issued
    2017
5 · Who and what money

Authors and funding

13 authors.

Huachun ZouSchool of Public Health, Sun Yat-sen University, Guangzhou, China.
Xiaojun MengDepartment of Infectious Disease Control, Wuxi Municipal Centre for Disease Control and Prevention, Wuxi, China.
Andrew GrulichKirby Institute, University of New South Wales, Sydney, Australia.
Shujie HuangDermatology Hospital, Southern Medical University, Guangzhou, China.
Tianjian JiaDepartment of Infectious Disease Control, Wuxi Municipal Centre for Disease Control and Prevention, Wuxi, China.
Xuan ZhangDepartment of Infectious Disease Control, Wuxi Municipal Centre for Disease Control and Prevention, Wuxi, China.
Zhenzhou LuoNanshan District Centre for Chronic Disease Control and Prevention, Shenzhen, China.
Yi DingNanshan District Centre for Chronic Disease Control and Prevention, Shenzhen, China.
Ligang YangDermatology Hospital, Southern Medical University, Guangzhou, China.
Jinmei HuangDermatology Hospital, Southern Medical University, Guangzhou, China.
Weiying ChenDermatology Hospital, Southern Medical University, Guangzhou, China.
Heping ZhengDermatology Hospital, Southern Medical University, Guangzhou, China.
Bin YangDermatology Hospital, Southern Medical University, Guangzhou, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionThe frequency of screening for HIV and other sexually transmitted infections (STIs) among men who have sex with men (MSM) is still low in China. METHODS AND ANALYSIS: A sexual health clinic based randomised controlled trial will be conducted in Guangzhou, Wuxi and Shenzhen, China, enrolling 600 MSM. Eligibility will be judged by the pre-programed iPad based questionnaire: (1) age ≥18 years and (2) have had two or more male anal sex partners, or condomless anal sex with a casual male sex partner, or an STI history, in the past 6 months, and (3) provides a valid mobile phone number. Eligible men will be randomly allocated 1:1 to the intervention arm (with monthly text messages reminding them to test for HIV/STIs) or to the control arm (with no reminders). Men in both arms will complete a questionnaire onsite at enrolment and after 12 months, and another questionnaire online at 6 months. Men in both arms will be tested for HIV, syphilis, anal gonorrhoea/chlamydia and penile gonorrhoea/chlamydia at enrolment and at 12 months. The primary outcome is the rate and frequency of HIV testing within the 12 months after enrolment. The secondary outcome is the rate of unprotected anal intercourse. An assessment of the cost effectiveness of this intervention is also planned. ETHICS AND DISSEMINATION: The study has been approved by the ethical review committees of the University of New South Wales, Australia (HC16803), the Guangdong Provincial Centre for Skin Disease and STI Control (GDDHLS-20160926) and the Wuxi Centre for Disease Control and Prevention (WXCDC2016009), China. Study findings will be submitted to academic journals and disseminated to local health authorities. TRIAL REGISTRATION NUMBER: Chinese Clinical Trial Registry at: http://www.chictr.org.cn/showprojen.aspx?proj=15752 and WHO International Clinical Trials Registry Platform at: http://apps.who.int/trialsearch/Trial2.aspx?TrialID=ChiCTR-IOR-16009304.

Indexed as

Homosexuality, MaleMass ScreeningText MessagingChinaCost-Benefit AnalysisHIV InfectionsHumansLost to Follow-UpMaleResearch DesignSexual BehaviorSexual HealthSexual PartnersSurveys and QuestionnairesSyphilisHIVMen who have sex with menReminderSexual health clinicSTIText message service

Identifiers

PMID28698334
PMCPMC5541733

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.